Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 7NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 3Thoracic 2Other solid neoplasm 2Genitourinary 2Gastrointestinal 2Breast 2Sarcoma 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 54Specimen Handling 48aldesleukin 35Docetaxel 30Biopsy 28Bevacizumab 24Gemcitabine 21Cyclophosphamide 21Cisplatin 21Radiotherapy 19Prednisone 17Sorafenib 16Carboplatin 16sargramostim 15PROSTVAC 15Paclitaxel 14Interferon-alpha 14Sunitinib 13ixabepilone 12cabozantinib 12Immunoglobulin G 12Goserelin 12Disulfides 12fludarabine phosphate 11fludarabine 11Nivolumab 11Fluorouracil 11Chemotherapy, Adjuvant 11pembrolizumab 10bicalutamide 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Diathermy × Genitourinary × Clear all
NCT01094964 2013-08-12

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
242 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00061867 2013-05-30

Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Completed
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡